Adoptive Cellular Immunotherapy Market Report

Global and Region Adoptive Cellular Immunotherapy Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：221
  • REPORT CODE：GMM924370
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Adoptive Cellular Immunotherapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Adoptive Cellular Immunotherapymarket, defines the market attractiveness level of Adoptive Cellular Immunotherapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Adoptive Cellular Immunotherapy industry, describes the types of Adoptive Cellular Immunotherapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Adoptive Cellular Immunotherapy market and the development prospects and opportunities of Adoptive Cellular Immunotherapy industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Adoptive Cellular Immunotherapy market in Chapter 13.

    By Player:

    • HRAIN Biotechnology Co Ltd

    • bluebird bio Inc

    • Gilead Sciences Inc

    • Takara Bio Inc

    • Nanjing Legend Biotech Co Ltd

    • Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

    • Nkarta Inc

    • Celgene Corp

    • Ono Pharmaceutical Co Ltd

    • CARsgen Therapeutics Ltd

    • Amgen Inc

    • Cell Medica Ltd

    • Autolus Therapeutics Plc

    • Guangzhou Anjie Biomedical Technology Co Ltd

    • Juno Therapeutics Inc

    • Celularity Inc

    • Fosun Pharmaceutical AG

    • Cellular Biomedicine Group Inc

    • Sorrento Therapeutics Inc

    • Kite Pharma Inc

    • NantKwest Inc

    • Hebei Senlang Biotechnology Inc Ltd

    • Beijing Immunochina Medical Science & Technology Co Ltd

    • Celyad SA

    • Hangzhou Converd Co Ltd

    • Daiichi Sankyo Co Ltd

    • Bristol-Myers Squibb Co

    • Novartis AG

    • Bellicum Pharmaceuticals Inc

    By Type:

    • TIL

    • LAK

    • CAR-T

    • TCR-T

    • CIK

    • NK

    • DC

    • Other

    By End-User:

    • Hospital

    • Cancer Hospital

    • Centers for Disease Control and Prevention

    • Rehabilitation Center

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Adoptive Cellular Immunotherapy Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Adoptive Cellular Immunotherapy Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Adoptive Cellular Immunotherapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Adoptive Cellular Immunotherapy Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Adoptive Cellular Immunotherapy Market Analysis and Outlook to 2022

    • 7.1 Global Adoptive Cellular Immunotherapy Consumption (2017-2022)

    • 7.2 United States Adoptive Cellular Immunotherapy Consumption (2017-2022)

    • 7.3 Europe Adoptive Cellular Immunotherapy Consumption (2017-2022)

    • 7.4 China Adoptive Cellular Immunotherapy Consumption (2017-2022)

    • 7.5 Japan Adoptive Cellular Immunotherapy Consumption (2017-2022)

    • 7.6 India Adoptive Cellular Immunotherapy Consumption (2017-2022)

    • 7.7 South Korea Adoptive Cellular Immunotherapy Consumption (2017-2022)

    8 Region and Country-wise Adoptive Cellular Immunotherapy Market Analysis and Outlook to 2028

    • 8.1 Global Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)

    • 8.2 United States Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)

    • 8.3 Europe Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)

    • 8.4 China Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)

    • 8.5 Japan Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)

    • 8.6 India Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)

    • 8.7 South Korea Adoptive Cellular Immunotherapy Consumption Forecast (2022-2028)

    9 Global Adoptive Cellular Immunotherapy Market Outlook by Types and Applications to 2022

    • 9.1 Global Adoptive Cellular Immunotherapy Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global TIL Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global LAK Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global CAR-T Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global TCR-T Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global CIK Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global NK Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global DC Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Adoptive Cellular Immunotherapy Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cancer Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Centers for Disease Control and Prevention Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Rehabilitation Center Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Adoptive Cellular Immunotherapy Market Outlook by Types and Applications to 2028

    • 10.1 Global Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global TIL Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global LAK Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global CAR-T Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global TCR-T Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global CIK Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global NK Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global DC Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cancer Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Centers for Disease Control and Prevention Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Rehabilitation Center Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Adoptive Cellular Immunotherapy Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Adoptive Cellular Immunotherapy Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Adoptive Cellular Immunotherapy Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Adoptive Cellular Immunotherapy Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Adoptive Cellular Immunotherapy Market Competitive Analysis

    • 14.1 HRAIN Biotechnology Co Ltd

      • 14.1.1 HRAIN Biotechnology Co Ltd Company Details

      • 14.1.2 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • 14.2 bluebird bio Inc

      • 14.2.1 bluebird bio Inc Company Details

      • 14.2.2 bluebird bio Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 bluebird bio Inc Adoptive Cellular Immunotherapy Product and Service

    • 14.3 Gilead Sciences Inc

      • 14.3.1 Gilead Sciences Inc Company Details

      • 14.3.2 Gilead Sciences Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Product and Service

    • 14.4 Takara Bio Inc

      • 14.4.1 Takara Bio Inc Company Details

      • 14.4.2 Takara Bio Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Takara Bio Inc Adoptive Cellular Immunotherapy Product and Service

    • 14.5 Nanjing Legend Biotech Co Ltd

      • 14.5.1 Nanjing Legend Biotech Co Ltd Company Details

      • 14.5.2 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • 14.6 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

      • 14.6.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details

      • 14.6.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • 14.7 Nkarta Inc

      • 14.7.1 Nkarta Inc Company Details

      • 14.7.2 Nkarta Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Nkarta Inc Adoptive Cellular Immunotherapy Product and Service

    • 14.8 Celgene Corp

      • 14.8.1 Celgene Corp Company Details

      • 14.8.2 Celgene Corp Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Celgene Corp Adoptive Cellular Immunotherapy Product and Service

    • 14.9 Ono Pharmaceutical Co Ltd

      • 14.9.1 Ono Pharmaceutical Co Ltd Company Details

      • 14.9.2 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • 14.10 CARsgen Therapeutics Ltd

      • 14.10.1 CARsgen Therapeutics Ltd Company Details

      • 14.10.2 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product and Service

    • 14.11 Amgen Inc

      • 14.11.1 Amgen Inc Company Details

      • 14.11.2 Amgen Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Amgen Inc Adoptive Cellular Immunotherapy Product and Service

    • 14.12 Cell Medica Ltd

      • 14.12.1 Cell Medica Ltd Company Details

      • 14.12.2 Cell Medica Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Product and Service

    • 14.13 Autolus Therapeutics Plc

      • 14.13.1 Autolus Therapeutics Plc Company Details

      • 14.13.2 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product and Service

    • 14.14 Guangzhou Anjie Biomedical Technology Co Ltd

      • 14.14.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details

      • 14.14.2 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • 14.15 Juno Therapeutics Inc

      • 14.15.1 Juno Therapeutics Inc Company Details

      • 14.15.2 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product and Service

    • 14.16 Celularity Inc

      • 14.16.1 Celularity Inc Company Details

      • 14.16.2 Celularity Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Celularity Inc Adoptive Cellular Immunotherapy Product and Service

    • 14.17 Fosun Pharmaceutical AG

      • 14.17.1 Fosun Pharmaceutical AG Company Details

      • 14.17.2 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product and Service

    • 14.18 Cellular Biomedicine Group Inc

      • 14.18.1 Cellular Biomedicine Group Inc Company Details

      • 14.18.2 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product and Service

    • 14.19 Sorrento Therapeutics Inc

      • 14.19.1 Sorrento Therapeutics Inc Company Details

      • 14.19.2 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product and Service

    • 14.20 Kite Pharma Inc

      • 14.20.1 Kite Pharma Inc Company Details

      • 14.20.2 Kite Pharma Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Product and Service

    • 14.21 NantKwest Inc

      • 14.21.1 NantKwest Inc Company Details

      • 14.21.2 NantKwest Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 NantKwest Inc Adoptive Cellular Immunotherapy Product and Service

    • 14.22 Hebei Senlang Biotechnology Inc Ltd

      • 14.22.1 Hebei Senlang Biotechnology Inc Ltd Company Details

      • 14.22.2 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product and Service

    • 14.23 Beijing Immunochina Medical Science & Technology Co Ltd

      • 14.23.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details

      • 14.23.2 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • 14.24 Celyad SA

      • 14.24.1 Celyad SA Company Details

      • 14.24.2 Celyad SA Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.24.3 Celyad SA Adoptive Cellular Immunotherapy Product and Service

    • 14.25 Hangzhou Converd Co Ltd

      • 14.25.1 Hangzhou Converd Co Ltd Company Details

      • 14.25.2 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.25.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • 14.26 Daiichi Sankyo Co Ltd

      • 14.26.1 Daiichi Sankyo Co Ltd Company Details

      • 14.26.2 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.26.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • 14.27 Bristol-Myers Squibb Co

      • 14.27.1 Bristol-Myers Squibb Co Company Details

      • 14.27.2 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.27.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product and Service

    • 14.28 Novartis AG

      • 14.28.1 Novartis AG Company Details

      • 14.28.2 Novartis AG Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.28.3 Novartis AG Adoptive Cellular Immunotherapy Product and Service

    • 14.29 Bellicum Pharmaceuticals Inc

      • 14.29.1 Bellicum Pharmaceuticals Inc Company Details

      • 14.29.2 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.29.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Adoptive Cellular Immunotherapy

    • Figure Adoptive Cellular Immunotherapy Picture

    • Table Global Adoptive Cellular Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Adoptive Cellular Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Adoptive Cellular Immunotherapy Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Adoptive Cellular Immunotherapy Consumption by Country (2017-2022)

    • Figure United States Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)

    • Table Europe Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure China Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Japan Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure India Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure South Korea Adoptive Cellular Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Adoptive Cellular Immunotherapy Consumption Forecast by Country (2022-2028)

    • Figure United States Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Adoptive Cellular Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global TIL Consumption and Growth Rate (2017-2022)

    • Figure Global LAK Consumption and Growth Rate (2017-2022)

    • Figure Global CAR-T Consumption and Growth Rate (2017-2022)

    • Figure Global TCR-T Consumption and Growth Rate (2017-2022)

    • Figure Global CIK Consumption and Growth Rate (2017-2022)

    • Figure Global NK Consumption and Growth Rate (2017-2022)

    • Figure Global DC Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Centers for Disease Control and Prevention Consumption and Growth Rate (2017-2022)

    • Figure Global Rehabilitation Center Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global TIL Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global LAK Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CAR-T Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global TCR-T Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CIK Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NK Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DC Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Centers for Disease Control and Prevention Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rehabilitation Center Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Adoptive Cellular Immunotherapy Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Adoptive Cellular Immunotherapy Export by Region (Top 5 Countries) (2017-2028)

    • Table HRAIN Biotechnology Co Ltd (Foundation Year, Company Profile and etc.)

    • Table HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • Table bluebird bio Inc (Foundation Year, Company Profile and etc.)

    • Table bluebird bio Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table bluebird bio Inc Adoptive Cellular Immunotherapy Product and Service

    • Table Gilead Sciences Inc (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Inc Adoptive Cellular Immunotherapy Product and Service

    • Table Takara Bio Inc (Foundation Year, Company Profile and etc.)

    • Table Takara Bio Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takara Bio Inc Adoptive Cellular Immunotherapy Product and Service

    • Table Nanjing Legend Biotech Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • Table Nkarta Inc (Foundation Year, Company Profile and etc.)

    • Table Nkarta Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nkarta Inc Adoptive Cellular Immunotherapy Product and Service

    • Table Celgene Corp (Foundation Year, Company Profile and etc.)

    • Table Celgene Corp Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corp Adoptive Cellular Immunotherapy Product and Service

    • Table Ono Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • Table CARsgen Therapeutics Ltd (Foundation Year, Company Profile and etc.)

    • Table CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Adoptive Cellular Immunotherapy Product and Service

    • Table Cell Medica Ltd (Foundation Year, Company Profile and etc.)

    • Table Cell Medica Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cell Medica Ltd Adoptive Cellular Immunotherapy Product and Service

    • Table Autolus Therapeutics Plc (Foundation Year, Company Profile and etc.)

    • Table Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product and Service

    • Table Guangzhou Anjie Biomedical Technology Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • Table Juno Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Juno Therapeutics Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product and Service

    • Table Celularity Inc (Foundation Year, Company Profile and etc.)

    • Table Celularity Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celularity Inc Adoptive Cellular Immunotherapy Product and Service

    • Table Fosun Pharmaceutical AG (Foundation Year, Company Profile and etc.)

    • Table Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product and Service

    • Table Cellular Biomedicine Group Inc (Foundation Year, Company Profile and etc.)

    • Table Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product and Service

    • Table Sorrento Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product and Service

    • Table Kite Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Kite Pharma Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kite Pharma Inc Adoptive Cellular Immunotherapy Product and Service

    • Table NantKwest Inc (Foundation Year, Company Profile and etc.)

    • Table NantKwest Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table NantKwest Inc Adoptive Cellular Immunotherapy Product and Service

    • Table Hebei Senlang Biotechnology Inc Ltd (Foundation Year, Company Profile and etc.)

    • Table Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product and Service

    • Table Beijing Immunochina Medical Science & Technology Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • Table Celyad SA (Foundation Year, Company Profile and etc.)

    • Table Celyad SA Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celyad SA Adoptive Cellular Immunotherapy Product and Service

    • Table Hangzhou Converd Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • Table Daiichi Sankyo Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product and Service

    • Table Bristol-Myers Squibb Co (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Adoptive Cellular Immunotherapy Product and Service

    • Table Bellicum Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US